Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors
about
Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in miceMetabotropic Glutamate Receptors 7 within the Nucleus Accumbens are Involved in Relief Learning in Rats.Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behaviorMetabotropic glutamate receptors: from the workbench to the bedside.Acute pharmacological modulation of mGluR8 reduces measures of anxiety.The clinical implications of mouse models of enhanced anxiety.Painful stimuli evoke potentials recorded from the medial temporal lobe in humans.Painful laser stimuli induce directed functional interactions within and between the human amygdala and hippocampus.Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons.The amygdala between sensation and affect: a role in pain.Homer1a signaling in the amygdala counteracts pain-related synaptic plasticity, mGluR1 function and pain behaviors.Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdalaTherapeutic potential of metabotropic glutamate receptor modulators.NMDA or non-NMDA receptor antagonism within the amygdaloid central nucleus suppresses the affective dimension of pain in rats: evidence for hemispheric synergy.Oscillatory EEG activity induced by conditioning stimuli during fear conditioning reflects Salience and Valence of these stimuli more than Expectancy.Amygdala pain mechanisms.Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain.The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersNeuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviorsForebrain pain mechanisms.Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat.Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.Supraspinal metabotropic glutamate receptor subtype 8: a switch to turn off pain.Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.Nociception modulation by supraspinal group III metabotropic glutamate receptors.Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4.Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia?Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions.
P2860
Q24630212-D45AB034-234A-4395-8458-C5DD4A282893Q30366694-F13B14E2-C121-4C3A-A8DB-39D8B9EF3064Q30414092-4C24AF4D-A91E-46B4-B121-D1902B0FAC6AQ30448778-F0E24549-AB95-40E2-88C6-6483A141B661Q30473719-38EF1F1C-8885-4359-8C74-D4B1B434276DQ30474232-928BBB5C-B489-4C71-94AC-6AAC4551B1F1Q30899499-4FC111D6-3138-497F-8786-D22CA4134738Q33800458-AB1AD699-BAE8-47C8-A9B5-B3AF91E6708CQ33995347-87D8E039-EEB1-4B8A-B8AF-ACA387904095Q34470331-619B1C5C-75FD-41ED-9403-1099B93BA96DQ35063684-742F7FDC-4FA8-4776-A072-405527C72E6EQ35292064-3DEEB803-342C-4040-A44D-64CB7C1DC0AAQ35778704-5098C7E9-E860-409E-9352-7C69EFE83458Q35898671-118269CC-96D2-42BB-98C0-8EC205D373B3Q36246803-93C31EE8-7357-4185-ACDB-CD3D375C8FCFQ36430485-4695DA9F-C25A-482B-926F-EB06E08BBDD9Q37103693-AFD12D4E-2A2D-49F9-B4E4-23AEB15BFFB4Q37114728-52B2ED23-E5C3-4FBD-80E4-998C9018B7D1Q37172873-B3B5371B-0ED8-46B3-A241-EE8046D46F26Q37235432-EBCBA23F-B776-4A6A-BFE2-06D17538AD0CQ37238581-F3365C72-7EA8-49AD-B255-1E7CAE37A165Q37355350-98CE316C-0FC0-4F1E-BA79-17A3154884BBQ37861794-16466F31-A7F5-4DCA-AFA8-F07AC37D455DQ38185074-D3BB0D2B-F9A7-4356-A470-7BE633251B61Q38195519-C735973B-52E6-4ED7-9BFF-7BE34483DB96Q38242117-FDB01A4D-CD87-4403-B90F-C4BF8614C8ABQ38865953-0E0B1EBC-E8F5-4BF4-932C-B59DA9476AD5Q38882060-D3AF0CE6-B7E2-47A8-A120-CE58CA8AA3E1Q39085798-BE759881-E644-439F-95D2-93F3025B4EF3Q41853358-EF184401-82F8-4BDB-AD0C-DED12BB63A39Q48826263-346BEEEC-AC8F-4170-884D-D28893DD192F
P2860
Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors
description
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im September 2008 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/09/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/09/01)
@nl
наукова стаття, опублікована у вересні 2008
@uk
مقالة علمية (نشرت في سبتمبر 2008)
@ar
name
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@ast
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@en
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@nl
type
label
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@ast
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@en
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@nl
prefLabel
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@ast
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@en
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@nl
P2093
P2860
P1433
P1476
Group III mGluR7 and mGluR8 in ...... e and affective pain behaviors
@en
P2093
Enza Palazzo
Guangchen Ji
Volker Neugebauer
P2860
P304
P356
10.1016/J.NEUROPHARM.2008.05.007
P577
2008-09-01T00:00:00Z